Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

David Rogers

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

November 15, 2024
Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.
Read Transcript

‍It’s one of the best known brands in the world but Estee Lauder has been pummeled.

‍

For Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

‍

In her Sohn Hearts & Minds Conference debut, Ms Wright says Estee Lauder is set to regain its premium share market valuation amid emerging “mega-trends” in the cosmetics industry.

‍

Estee Lauder shares rose five fold in the five-years to the start of 2022. Its skin care and travel retail divisions were driving-double digit organic sales growth and strong margin expansion. The company had an enviable track record and brand and still does.

‍

Despite the initial uncertainty of Covid, e-commerce took off and the removal of travel restrictions in the US and Europe had Estee management primed for China’s reopening.

‍

“But then, just like that, the party stopped,” Wright said.

‍

“China didn’t reopen, Asia slowed, and US and European ‘revenge spend’ abated.

‍

“Estee found itself with too much product in the wrong place at the wrong time.”

‍

At that point the company suffered from an excess of inventory built up to meet demand during the pandemic, losing about 80 percent of its value over the next two years.

‍

At current levels around $US64.83 versus a record high of $US374.20 in early 2022, the share price is well below the levels where Northcape began buying in 2019.

‍

“But I’m here to tell you that the worst is over,” Wright said.

‍

The company now has a restructuring plan to boost its profit by $US1.4bn by 2026.

‍

That’s 80 per cent of the profit that the company delivered last year.

‍

“Now we also have a catalyst after their poor performance in recent years,” Wright said.

‍

“We have a whole new senior management team ready to take estate to the next level.

‍

“Put those earnings on Estee’s historic PE multiple, and you get a share price return that is more than double.

‍

“This is one of those rare times to buy a quality company at an attractive price.”

‍

With a $25bn market capitalisation, the US-listed cosmetics company doesn’t just own the Estee Lauder brand. It has over 20 well known global premium beauty brands.

‍

It’s a big part of why its share price has historically commanded a PE premium of 1.7 times, which is what Northcape paid for the shares when it launched its global equity fund in 2019.

‍

“It’s a great example of the type of high quality business I like to invest in,” Wright said.

‍

“It meets all of North Cape’s quality principles, meaning it can sustainably generate returns well above its cost of capital reinvest and grow and hence to live on long term share price out performance.”

‍

Estee is the third biggest cosmetics maker globally, with huge economies of scale in research and development, manufacturing and marketing. It also dominates in “prestige beauty”, where there’s less competition and brand recognition and luxury reputation are “really hard to replicate”.

‍

It’s also in a growth industry, one where Estee has a long track record of outperforming by over 50 per cent, with mid-single plus organic sales growth for over the past 30 years.

‍

Ongoing China stimulus measures could provide a boost, as while cosmetics are thought to be a discretionary spending item, they have actually historically behaved more Like a staple.

‍

Former CEO Leonard Lauder coined it the “lipstick effect”, after observing the purchases of affordable luxuries like lipstick, actually tended to go up as economic growth rates fell.

‍

“So whilst I might be worried about a recession (in China) in coming years, I’m a whole lot less worried about its impact on Estee,” Wright added.

‍

But she also sees “mega trends” driving long-term growth for Estee Lauder.

‍

Firstly, spending per capita has room to grow because consumers in emerging markets countries are spending only a fraction on beauty products compared to the US, Europe and Japan.

‍

Secondly, consumers tend to spend more on beauty products as they age. For countries like China where population growth has stopped, the average age of people is getting older.

‍

Third, additional growth categories are opening up with the help of innovation into areas like home fragrances. Finally, men are increasingly starting to use cosmetics.

‍

“Together, these factors should help return Estee to its mid- to-high single digit organic growth trajectory, and importantly, I think they can do a whole lot better than this,” Wright said.

‍

“After the recent years of declines, Estee can grow again.”

‍

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

‍It’s one of the best known brands in the world but Estee Lauder has been pummeled.

‍

For Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

‍

In her Sohn Hearts & Minds Conference debut, Ms Wright says Estee Lauder is set to regain its premium share market valuation amid emerging “mega-trends” in the cosmetics industry.

‍

Estee Lauder shares rose five fold in the five-years to the start of 2022. Its skin care and travel retail divisions were driving-double digit organic sales growth and strong margin expansion. The company had an enviable track record and brand and still does.

‍

Despite the initial uncertainty of Covid, e-commerce took off and the removal of travel restrictions in the US and Europe had Estee management primed for China’s reopening.

‍

“But then, just like that, the party stopped,” Wright said.

‍

“China didn’t reopen, Asia slowed, and US and European ‘revenge spend’ abated.

‍

“Estee found itself with too much product in the wrong place at the wrong time.”

‍

At that point the company suffered from an excess of inventory built up to meet demand during the pandemic, losing about 80 percent of its value over the next two years.

‍

At current levels around $US64.83 versus a record high of $US374.20 in early 2022, the share price is well below the levels where Northcape began buying in 2019.

‍

“But I’m here to tell you that the worst is over,” Wright said.

‍

The company now has a restructuring plan to boost its profit by $US1.4bn by 2026.

‍

That’s 80 per cent of the profit that the company delivered last year.

‍

“Now we also have a catalyst after their poor performance in recent years,” Wright said.

‍

“We have a whole new senior management team ready to take estate to the next level.

‍

“Put those earnings on Estee’s historic PE multiple, and you get a share price return that is more than double.

‍

“This is one of those rare times to buy a quality company at an attractive price.”

‍

With a $25bn market capitalisation, the US-listed cosmetics company doesn’t just own the Estee Lauder brand. It has over 20 well known global premium beauty brands.

‍

It’s a big part of why its share price has historically commanded a PE premium of 1.7 times, which is what Northcape paid for the shares when it launched its global equity fund in 2019.

‍

“It’s a great example of the type of high quality business I like to invest in,” Wright said.

‍

“It meets all of North Cape’s quality principles, meaning it can sustainably generate returns well above its cost of capital reinvest and grow and hence to live on long term share price out performance.”

‍

Estee is the third biggest cosmetics maker globally, with huge economies of scale in research and development, manufacturing and marketing. It also dominates in “prestige beauty”, where there’s less competition and brand recognition and luxury reputation are “really hard to replicate”.

‍

It’s also in a growth industry, one where Estee has a long track record of outperforming by over 50 per cent, with mid-single plus organic sales growth for over the past 30 years.

‍

Ongoing China stimulus measures could provide a boost, as while cosmetics are thought to be a discretionary spending item, they have actually historically behaved more Like a staple.

‍

Former CEO Leonard Lauder coined it the “lipstick effect”, after observing the purchases of affordable luxuries like lipstick, actually tended to go up as economic growth rates fell.

‍

“So whilst I might be worried about a recession (in China) in coming years, I’m a whole lot less worried about its impact on Estee,” Wright added.

‍

But she also sees “mega trends” driving long-term growth for Estee Lauder.

‍

Firstly, spending per capita has room to grow because consumers in emerging markets countries are spending only a fraction on beauty products compared to the US, Europe and Japan.

‍

Secondly, consumers tend to spend more on beauty products as they age. For countries like China where population growth has stopped, the average age of people is getting older.

‍

Third, additional growth categories are opening up with the help of innovation into areas like home fragrances. Finally, men are increasingly starting to use cosmetics.

‍

“Together, these factors should help return Estee to its mid- to-high single digit organic growth trajectory, and importantly, I think they can do a whole lot better than this,” Wright said.

‍

“After the recent years of declines, Estee can grow again.”

‍

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on November 15, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jeremy Bond presenting at 2023 Sohn Hearts & Minds ConferenceJeremy Bond presenting at 2023 Sohn Hearts & Minds ConferenceJeremy Bond presenting at 2023 Sohn Hearts & Minds ConferenceJeremy Bond presenting at 2023 Sohn Hearts & Minds Conference
September 21, 2026

An Australian fund manager finds redemption in the copper boom

Bond is in hot demand. He’s one of only a handful of speakers invited to return to the Sohn Hearts and Minds charity stockpicking conference, which is being held this year in Queenstown.

Read More
September 23, 2026

‘What is GDP for?’: Strategist Michael Every on the dangers of Australia ignoring economic risks

According to Singapore-based global strategist with Rabobank Michael Every, countries have spent decades optimising for quarterly or annual GDP numbers without asking what growth is actually for: and that is safety, sovereignty and resilience.

Read More
September 23, 2026

He nailed Trump’s big plan. Now he fears Australia’s China-US squeeze

Strategist Michael Every says Trump’s economic statecraft is working, even when it looks messy. But he fears a moment of truth is coming for Australia.

Read More
October 14, 2026

Why US banks are opening new branches, not closing them

US banks are reopening physical branches to attract deposits, strengthen customer relationships and gain market share, showing that face-to-face banking remains valuable despite the shift to digital services.

Read More
October 18, 2026

‘Critically underpriced’

Robert Mullin tips resources surge as AI forces energy market reset

Read More
October 23, 2026

Fundie's stock tips need to pass the dinner party test

John Pinkel backs his conviction in overlooked stocks, from AI chipmaker SK Hynix to sportswear brand ASICS. David Rogers examines the Indus Capital fund manager’s contrarian approach and how he spots opportunities others miss.

Read More
October 24, 2026

Why Samantha D'Amore of Cymer Capital is looking beyond US

Samantha D'Amore shares where she's finding compelling opportunities beyond the US and the global themes shaping her investment approach.

Read More
All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.
November 8, 2026

The big lesson for fundies at Sohn came from an All Blacks veteran

At this year’s high-profile stock picking conference, Dan Carter sat down with ex-rugby league star Cooper Cronk and delivered a cut-through message on pressure.

Read More
Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.
November 6, 2026

Anthropic backer says ‘be long’ on AI as tech rout rips across Asia

Anthropic backer remains bullish on AI despite Asia's tech sell-off.

Read More
David Allen at the Sohn Hearts & Minds Conference Investment Conference in Queenstown.David Allen at the Sohn Hearts & Minds Conference Investment Conference in Queenstown.David Allen at the Sohn Hearts & Minds Conference Investment Conference in Queenstown.David Allen at the Sohn Hearts & Minds Conference Investment Conference in Queenstown.
November 6, 2026

Plato's Allen says Anthropic has 14 red flags

Plato's David Allen identifies 14 red flags at Anthropic, raising concerns over AI valuations.

Read More
Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.
November 6, 2026

War on the weekend? Strategist's startling Iran warning

Markets are focused on the AI wreck. But Rabobanks Michael Every says the drums of war haven't stopped beating.

Read More
Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.
November 6, 2026

Northcape's Ross Cameron pitches Coway

Ross Cameron pitches South Korean home appliance company Coway as a compelling investment opportunity.

Read More
Northcape's Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Northcape's Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Northcape's Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Northcape's Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.
November 6, 2026

Northcape's Cameron tips Coway at Sohn

Northcape's Ross Cameron pitches South Korean home appliance company Coway at Sohn.

Read More
Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.
November 6, 2026

Cymer Capital's D'Amore tips Fast Retailing

Cymer Capital's Samantha D'Amore pitches Japanese retail giant Fast Retailing at Sohn Hearts & Minds Conference 2026.

Read More
Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.Cymer Capital's Samantha D'Amore at the Sohn Hearts & Minds Conference in Queenstown.
November 6, 2026

Cymer's Samantha D'Amore picks Fast Retailing

Cymer Capital's Samantha D'Amore backs Fast Retailing at Sohn Hearts & Minds 2026.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.